<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="2979">Baicalein</z:chebi> is the <z:chebi fb="5" ids="47916">flavonoids</z:chebi> with multiple pharmacological activities </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of our study was to investigate the effects of <z:chebi fb="0" ids="2979">baicalein</z:chebi> on <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and to recognize the targets of <z:chebi fb="0" ids="2979">baicalein</z:chebi> treatment </plain></SENT>
<SENT sid="2" pm="."><plain>To better understand <z:chebi fb="0" ids="2979">baicalein</z:chebi>'s target, proteomic approaches were used to purify and identify the protein substrates using 2D difference gel electrophoresis (2D <z:chebi fb="26" ids="8984">SDS</z:chebi>-PAGE) to elucidate proteins differential display </plain></SENT>
<SENT sid="3" pm="."><plain>Results from this study investigate that <z:chebi fb="0" ids="2979">baicalein</z:chebi> treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells results in <z:mp ids='MP_0000352'>reduced cell proliferation</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>As a result, differential protein displays between <z:chebi fb="0" ids="2979">baicalein</z:chebi>-treated and untreated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were determined and validated </plain></SENT>
<SENT sid="5" pm="."><plain>There were 11 differentially expressed proteins between <z:chebi fb="0" ids="2979">baicalein</z:chebi>-treated and untreated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, we demonstrate that <z:chebi fb="0" ids="2979">baicalein</z:chebi> inhibits <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell proliferation and reduced reactive oxygen species (ROS) by up-regulating the levels of peroxiredoxin-6 (PRDX6) </plain></SENT>
<SENT sid="7" pm="."><plain>Knockdown of PRDX6 in <z:chebi fb="0" ids="2979">baicalein</z:chebi>-treated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells by specific small interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> resulted in ROS production and proliferation, opposite of the <z:chebi fb="0" ids="2979">baicalein</z:chebi> treatment scenario as indicated by cell cycle distribution </plain></SENT>
<SENT sid="8" pm="."><plain>These results illustrate that <z:chebi fb="0" ids="2979">baicalein</z:chebi> up-regulates the expression of PRDX6, which attenuates the generation of ROS and inhibits the growth of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, whereas <z:chebi fb="0" ids="2979">baicalein</z:chebi> treatment have no effect on <z:mpath ids='MPATH_458'>normal</z:mpath> epithelial cells </plain></SENT>
</text></document>